Intimation under Reg 30 of SEBI (LODR) Reg 2015 regarding completion of transfer of the entire equity stake of Mitsubishi Corporation held in Sastasundar Healthbuddy Limited, material subsidiary ....
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 3.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Health X Platform Limited has disclosed the completion of a share transfer transaction where Mitsubishi Corporation sold its entire 4.68% stake (10,13,766 equity shares) in Sastasundar Healthbuddy Limited, a material subsidiary, to Envision India Fund. The transaction was completed on May 12, 2026. The board of directors of Sastasundar Healthbuddy Limited noted the transfer at its board meeting on May 15, 2026. Following this transfer, Mitsubishi Corporation has ceased to be a shareholder of the subsidiary. This follows a share purchase agreement disclosed earlier on February 25, 2026.
Mitsubishi Corporation's complete exit from Sastasundar Healthbuddy Limited reduces the subsidiary's international institutional backing. The entry of Envision India Fund as a new shareholder may signal renewed strategic interest in the digital health platform, but the 4.68% stake sale is below the 5% disclosure threshold and has limited direct impact on Health X Platform Limited's own shareholding.